| Patent | Date |
|---|
Primary NK CAR Constructs And Methods
App 20220282216 - Parviz; Fereshteh ; et al. | 2022-09-08 |
Antibody Pre-loaded Cd16+nk-92 Cells As An Effective Therapeutic Product For Tumor Lysis
App 20220265716 - Simon; Barry ; et al. | 2022-08-25 |
Combination Therapies For Multiple Myeloma
App 20220257649 - Lee; John ; et al. | 2022-08-18 |
Recombinant erIL-15 NK cells
Grant 11,364,265 - Soon-Shiong , et al. June 21, 2 | 2022-06-21 |
Generating CIK NKT cells from cord blood
Grant 11,351,196 - Duggal , et al. June 7, 2 | 2022-06-07 |
RECOMBINANT erIL-15 NK CELLS
App 20220168349 - Soon-Shiong; Patrick ; et al. | 2022-06-02 |
Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells
App 20220144952 - Klingemann; Hans G. ; et al. | 2022-05-12 |
Generating Cik Nkt Cells From Cord Blood
App 20220133789 - DUGGAL; Rohit ; et al. | 2022-05-05 |
Tumoricidal and antimicrobial compositions and methods
Grant 11,304,977 - Klingemann , et al. April 19, 2 | 2022-04-19 |
Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors
Grant 11,230,699 - Lee , et al. January 25, 2 | 2022-01-25 |
Il-2 Dependent Nk-92 Cells With Stable Fc Receptor Expression
App 20220017594 - Navarro; Francisco ; et al. | 2022-01-20 |
Tumoricidal and antimicrobial compositions and methods
Grant 11,213,547 - Klingemann , et al. January 4, 2 | 2022-01-04 |
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
Grant 11,207,350 - Lee , et al. December 28, 2 | 2021-12-28 |
Optimization Of Nk-92 Cell Growth Using Poloxamer
App 20210363484 - BESSETTE; Shannyn ; et al. | 2021-11-25 |
Chemokine Responsive Activated Natural Killer Cells With Secondary Homing Activation For Verified Targets
App 20210324042 - SCHOMER; Nathan ; et al. | 2021-10-21 |
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
Grant 11,129,850 - Klingemann , et al. September 28, 2 | 2021-09-28 |
Combined Invasion And Cytotoxicity Assay Using Chemokine Secreting Target Cells
App 20210293787 - Schomer; Nathan Thomas ; et al. | 2021-09-23 |
Cryopreservation
App 20210267190 - BESSETTE; Shannyn ; et al. | 2021-09-02 |
Chimeric Antigen Receptor-Modified NK-92 Cells
App 20210260116 - Boissel; Laurent H. ; et al. | 2021-08-26 |
Genetically Modified Nk-92 Cells And Monoclonal Antibodies For The Treatment Of Cancer
App 20210236550 - Lee; Tien ; et al. | 2021-08-05 |
Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cells
Grant 11,077,143 - Klingemann , et al. August 3, 2 | 2021-08-03 |
Chimeric Antigen Receptor-modified Nk-92 Cells Targeting Egfr Super-family Receptors
App 20210230547 - Lee; John H. ; et al. | 2021-07-29 |
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
Grant 11,058,723 - Klingemann , et al. July 13, 2 | 2021-07-13 |
Generating Cik Nkt Cells From Cord Blood
App 20210205367 - DUGGAL; Rohit ; et al. | 2021-07-08 |
FC-EPSILON CAR (Very imp commercially - in clinical trial)
App 20210198342 - Boissel; Laurent H. ; et al. | 2021-07-01 |
Basal Media For Growing Nk-92 Cells
App 20210198628 - ANDERSON; Richard John ; et al. | 2021-07-01 |
NK-92 Cells to Stimulate Anti-Cancer Vaccine
App 20210187024 - Klingemann; Hans G. ; et al. | 2021-06-24 |
Screening of cell clones expressing polygenic transgenes through non-antibiotic dependent positive selection
App 20210169931 - Boissel; Laurent H. ; et al. | 2021-06-10 |
Methods And Systems For Cell Bed Formation During Bioprocessing
App 20210163868 - BESSETTE; Shannyn ; et al. | 2021-06-03 |
Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment
App 20210145879 - Lee; John H. ; et al. | 2021-05-20 |
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
Grant 11,000,550 - Lee , et al. May 11, 2 | 2021-05-11 |
NK-92 Bone and Brain targeting
App 20210106619 - Lee; John H. | 2021-04-15 |
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
Grant 10,960,024 - Klingemann , et al. March 30, 2 | 2021-03-30 |
Modified Nk-92 Cells For Treating Cancer
App 20210054337 - Lee; Tien | 2021-02-25 |
Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation
App 20210040175 - Klingemann; Hans G. ; et al. | 2021-02-11 |
Use Of Cd33car Modified High Affinity Nk Cells (t-hank) To Reduce Myeloid-derived Suppressor Cells Suppressor Activity (or Reduce Negative Impact On Nk Cell Activity)
App 20210038645 - Soon-Shiong; Patrick ; et al. | 2021-02-11 |
Use Of 5% Human Albumin In Wash And Harvest Media
App 20210040451 - BESSETTE; Shannyn ; et al. | 2021-02-11 |
CIML NK cells and Methods Therefor
App 20210008107 - Duggal; Rohit ; et al. | 2021-01-14 |
CIML NK cells and Methods Therefor
App 20210008112 - Duggal; Rohit ; et al. | 2021-01-14 |
Mononuclear Cell Derived NK Cells
App 20210009954 - Duggal; Rohit ; et al. | 2021-01-14 |
Mononuclear Cell Derived NK Cells
App 20210009953 - Duggal; Rohit ; et al. | 2021-01-14 |
Elimination Of Cd19-positive Lymphoid Malignancies By Cd19-car Expressing Nk Cells
App 20200376033 - Klingemann; Hans G. ; et al. | 2020-12-03 |
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
App 20200347351 - Klingemann; Hans ; et al. | 2020-11-05 |
Modified NK-92 haNK003 cells for the clinic
Grant 10,801,013 - Klingemann , et al. October 13, 2 | 2020-10-13 |
Genetically Modified Nk-92 Cells And Monoclonal Antiboides For The Treatment Of Cancer
App 20200306312 - Lee; Tien ; et al. | 2020-10-01 |
Treating And Inhibiting Leukemia With Nk-92 Cells
App 20200306302 - Klingemann; Hans G. ; et al. | 2020-10-01 |
Tumoricidal and antimicrobial composition
Grant 10,772,912 - Klingemann , et al. Sept | 2020-09-15 |
Modified NK-92 haNK003 cells for the clinic
Grant 10,774,310 - Klingemann , et al. Sept | 2020-09-15 |
Elimination of CD19-positive lymphoid malignancies by CD19-CAR expressing NK cells
Grant 10,765,701 - Klingemann , et al. Sep | 2020-09-08 |
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
Grant 10,736,921 - Lee , et al. A | 2020-08-11 |
Modified NK-92 cells for treating cancer
Grant 10,738,279 - Lee A | 2020-08-11 |
Methods For Treating Merkel Cell Carcinoma (mcc) Using Nk-92 Cells
App 20200171087 - Klingemann; Hans ; et al. | 2020-06-04 |
Anti-egfr/high Affinity Nk-cells Compositions And Methods For Chordoma Treatment
App 20200155599 - Soon-Shiong; Patrick ; et al. | 2020-05-21 |
Tumoricidal and antimicrobial compositions and methods
Grant 10,646,516 - Klingemann , et al. | 2020-05-12 |
Elimination Of Pd-l1-positive Malignancies By Pd-l1 Chimeric Antigen Receptor-expressing Nk Cells
App 20200129552 - Klingemann; Hans G. ; et al. | 2020-04-30 |
Elimination Of Cd19-positive Lymphoid Malignancies By Cd19-car Expressing Nk Cells
App 20200129553 - Klingemann; Hans G. ; et al. | 2020-04-30 |
Genetically Modified Nk-92 Cells With Decreased Cd96/tigit Expression
App 20200123503 - Navarro; Francisco ; et al. | 2020-04-23 |
Nk-92 Cells And Il-15 Agonist Combination Therapy
App 20200121720 - Klingemann; Hans ; et al. | 2020-04-23 |
Quadricistronic System Comprising A Homing Receptor And Chimeric Antigen Receptor For Stable Genetic Modification Of Cellular Im
App 20200101111 - Klingemann; Hans G. ; et al. | 2020-04-02 |
Sample Destruction Validation System And Methods
App 20200096511 - Witchey; Nicholas J. | 2020-03-26 |
Quadricistronic System Comprising A Homing Receptor And Chimeric Antigen Receptor For Stable Genetic Modification Of Cellular Im
App 20200093863 - Klingemann; Hans G. ; et al. | 2020-03-26 |
Quadricistronic System Comprising A Homing Receptor And Chimeric Antigen Receptor For Stable Genetic Modification Of Cellular Im
App 20200038441 - Klingemann; Hans G. ; et al. | 2020-02-06 |
Tumoricidal And Antimicrobial Compositions And Methods
App 20200038445 - Klingemann; Hans G. ; et al. | 2020-02-06 |
Tumoricidal and antimicrobial compositions and methods
Grant 10,517,895 - Klingemann , et al. Dec | 2019-12-31 |
Genetically Modified Nk-92 Cells And Monoclonal Antiboides For The Treatment Of Cancer
App 20190365816 - Lee; Tien ; et al. | 2019-12-05 |
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
Grant 10,456,420 - Lee , et al. Oc | 2019-10-29 |
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
App 20190300854 - Klingemann; Hans ; et al. | 2019-10-03 |
Hdac Inhibitors For Use With Nk Cell Based Therapies
App 20190290646 - WOODY; James N. ; et al. | 2019-09-26 |
Hla Class I-deficient Nk-92 Cells With Decreased Immunogenicity
App 20190233797 - Navarro; Francisco ; et al. | 2019-08-01 |
Tumoricidal And Antimicrobial Compositions And Methods
App 20190192570 - Klingemann; Hans G. ; et al. | 2019-06-27 |
Tumoricidal And Antimicrobial Compositions And Methods
App 20190192569 - Klingemann; Hans G. ; et al. | 2019-06-27 |
Tumoricidal And Antimicrobial Compositions And Methods
App 20190192568 - Klingemann; Hans G. ; et al. | 2019-06-27 |
Tumoricidal And Antimicrobial Compositions And Methods
App 20190125801 - Klingemann; Hans G. ; et al. | 2019-05-02 |
Tumoricidal and antimicrobial compositions and methods
Grant 10,258,649 - Klingemann , et al. | 2019-04-16 |
Compositions and Methods for Treatment of Her2 Positive Metastatic Breast Cancer
App 20180360881 - Rabizadeh; Shahrooz ; et al. | 2018-12-20 |
Natural killer cell lines and methods of use
Grant 10,138,462 - Klingemann Nov | 2018-11-27 |
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
App 20180258397 - Klingemann; Hans ; et al. | 2018-09-13 |
Genetically Modified Nk-92 Cells And Monoclonal Antibodies For The Treatment Of Cancer
App 20180193383 - Lee; Tien ; et al. | 2018-07-12 |
Modified Nk-92 Cells For Treating Cancer
App 20180163176 - Lee; Tien | 2018-06-14 |
Nk-92 Cells In Combination Therapy With Cancer Drugs
App 20170304364 - Lee; Tien ; et al. | 2017-10-26 |
Treating Viral Hemorrhagic Fever With Nk-92 Cells
App 20170246209 - Lee; Tien ; et al. | 2017-08-31 |
Treating Solid Tumours With Nk-92 Cells Applied By Microcatheter
App 20170182292 - Klingemann; Hans G. | 2017-06-29 |
Tumoricidal And Antimicrobial Compositions And Methods
App 20160250256 - Klingemann; Hans G. ; et al. | 2016-09-01 |
Protocol And Media For Storage And Transport Of Nk-92 Cell Line
App 20160244716 - Klingemann; Hans G. ; et al. | 2016-08-25 |
| 